The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Stem Cell Umbilical Cord Blood Market Over The 2026–2030 Period?
The stem cell umbilical cord blood market has seen rapid expansion in recent years. Its value is set to increase from $7.98 billion in 2025 to $9.39 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.7%. Historically, this growth can be linked to the rising utilization of stem cell transplants, the expansion of public cord blood banks, developments in hematological treatments, increasing public understanding of stem cell therapies, and improvements in neonatal healthcare infrastructure.
The stem cell umbilical cord blood market size is anticipated to experience substantial growth in the coming years. This market is projected to expand to $17.83 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.4%. This projected growth is driven by several factors, including the increasing demand for personalized regenerative therapies, rising investments in cell therapy research, the expansion of treatments for neurological and immune disorders, the growing adoption of hybrid banking models, and advancements in stem cell expansion technologies. Significant trends for the forecast period involve a greater adoption of advanced cryopreservation technologies, the increasing utilization of stem cells in regenerative medicine, the ongoing expansion of private cord blood banking services, an enhanced focus on preserving cell quality and viability, and the spread of hybrid cord blood storage models.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24715&type=smp
What Underlying Factors Are Accelerating The Growth Of The Stem Cell Umbilical Cord Blood Market?
The stem cell umbilical cord blood market is expected to grow in the future, driven by increasing childbirth rates. Childbirth rates are defined as the number of live births per 1,000 people in a given population, typically over one year. The rise in these rates is attributed to the enhanced availability and affordability of fertility treatments, which enable more families to have children. Umbilical cord blood stem cells are valuable for newborns as they contain hematopoietic stem cells capable of treating various blood, immune, and genetic disorders. These cells provide a perfect genetic match for the baby and can also benefit siblings or other family members. For instance, in April 2025, the U.S. Centers for Disease Control and Prevention, a U.S.-based federal agency, reported that the number of births in the USA increased from 3,596,017 in 2023 to 3,622,673 in 2024, showing a 1% growth. Thus, the increasing childbirth rates are propelling the expansion of the stem cell umbilical cord blood market.
How Is The Stem Cell Umbilical Cord Blood Market Segmented Across Key Categories?
The stem cell umbilical cord blood market covered in this report is segmented –
1) By Product Type: Cord Blood Stem Cells, Cord Tissue Stem Cells
2) By Technology: Cryopreservation, Stem Cell Expansion, Cell Separation
3) By Storage Services: Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks
4) By Application: Hematological Disorders, Metabolic Diseases, Immune System Disorders, Neurological Disorders, Other Applications
5) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users
Subsegments:
1) By Cord Blood Stem Cells: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Endothelial Progenitor Cells, Regulatory T Cells, Natural Killer Cells, Dendritic Cells
2) By Cord Tissue Stem Cells: Mesenchymal Stem Cells, Epithelial Cells, Fibroblasts, Neural Progenitor Cells
Which Trends Are Influencing The Stem Cell Umbilical Cord Blood Market?
Companies operating in the stem cell umbilical cord blood market are increasingly concentrating on the creation of novel therapies and securing approvals, such as cord blood cell therapy designed to address rare genetic conditions, enhance immune system recuperation, and advance regenerative medicine applications. Cord blood cell therapy utilizes stem cells sourced from umbilical cord blood to manage various ailments by regenerating or mending damaged blood, immune, and other tissue systems. For instance, in October 2024, StemCyte, a US-based biotechnology company, obtained the regenerative medicine advanced therapy designation from the U.S. Food and Drug Administration (FDA) for its hematopoietic progenitor cell cord blood therapy (HPC Cord Blood), intended for treating Long COVID-19 syndrome. This specific cord blood cell therapy harnesses stem cells from umbilical cord blood to foster healing and mitigate inflammation. It demonstrates potential in addressing immune-related and degenerative conditions, providing a non-invasive, ethically sourced alternative for advanced regenerative treatments.
Who Are The Dominant Players Shaping The Stem Cell Umbilical Cord Blood Market Landscape?
Major companies operating in the stem cell umbilical cord blood market are Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, StemLife Berhad, MediPost Co Ltd, Smart Cells International Ltd, StemCyte Inc, Celularity Inc, Next Biosciences Pty Ltd, Esperite NV, Cryo Cell International Inc, FamiCord Group, Cells4Life Group LLP, Cryoviva Biotech Pvt Ltd, Americord Registry LLC, ViaCord LLC, China Cord Blood Corporation, CBR Systems Inc, Cord Blood Registry, LifeCell International Pvt Ltd, CryoSave India Pvt Ltd
Read the full stem cell umbilical cord blood market report here:
Which Region Is Projected To Dominate The Stem Cell Umbilical Cord Blood Market During The Forecast Period?
North America was the largest region in the stem cell umbilical cord blood market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell umbilical cord blood market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Stem Cell Umbilical Cord Blood Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24715&type=smp
Browse Through More Reports Similar to the Global Stem Cell Umbilical Cord Blood Market 2026, By The Business Research Company
Stem Cell Global Market Report
https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report
Stem Cells Therapy Global Market Report
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Stem Cell Assay Global Market Report
https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model